Mirabegron

Details

Files

Generic Name:

Mirabegron

Project Status:

Withdrawn

Therapeutic Area:

Overactive bladder

Manufacturer:

Astellas Pharma Canada, Inc.

Call for patient/clinician input open:

March 8, 2013

Brand Name:

Myrbetriq

Project Line:

Reimbursement Review

Project Number:

SR0319-000

Call for patient/clinician input closed:

April 1, 2013

Submission Type:

Initial

Indications:

Bladder, Overactive

Files

Submission Status Report View PDF

Last Updated : March 8, 2013